Skip to main content

Table 2 Multivariate prognostic analysis for PFS and OS

From: Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program

 

beta

E.S.

Signif.

HR

PFS

Myxoid LPS

−0.544

0.284

0.056

0.580

 

Line of treatment

0.272

0.117

0.020

1.312

OS

Myxoid LPS

−0.970

0.241

0.000

0.379

 

Retroperitoneal STS

−0.524

0.209

0.012

0.592